MedTrace Logo

G7 BiSpherical Acetabular Shell PMCF Study

NCT03266874 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-06-25

No results posted yet for this study

Summary

The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available G7 BiSpherical Acetabular Shell.

Conditions

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Noninflammatory Degenerative Joint Disease
  • Avascular Necrosis
  • Correction of Functional Deformity
  • Non-Union Fracture
  • Femoral Neck Fractures
  • Trochanteric Fractures

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hassan Achakri · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-10
Primary Completion
2029-12-31
Completion
2031-12-31

Countries

  • France
  • Germany
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266874 on ClinicalTrials.gov